# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000310158-20-000009
Filing Date
2020-05-06
Accepted
2020-05-06 16:36:54
Documents
87
Period of Report
2020-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mrk0331202010q.htm iXBRL | 10-Q | 2829842
2 | EXHIBIT 31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO 1Q20 | exhibit311rule13a-14a1.htm | EX-31.1 | 8665
3 | EXHIBIT 31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO 1Q20 | exhibit312rule13a-14a1.htm | EX-31.2 | 8698
4 | EXHIBIT 32.1 SECTION 1350 CERTIFICATION OF CEO 1Q20 | exhibit321section1350c.htm | EX-32.1 | 5199
5 | EXHIBIT 32.2 SECTION 1350 CERTIFICATION OF CFO 1Q20 | exhibit322section1350c.htm | EX-32.2 | 5501
| Complete submission text file | 0000310158-20-000009.txt |  | 13622022

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20200331.xsd | EX-101.SCH | 59691
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20200331_cal.xml | EX-101.CAL | 103445
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20200331_def.xml | EX-101.DEF | 357434
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20200331_lab.xml | EX-101.LAB | 811780
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20200331_pre.xml | EX-101.PRE | 502279
70 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk0331202010q_htm.xml | XML | 3663350

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 20853161
SIC: 2834 Pharmaceutical Preparations